These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22448469)

  • 21. Pregabalin abuse among opiate addicted patients.
    Grosshans M; Lemenager T; Vollmert C; Kaemmerer N; Schreiner R; Mutschler J; Wagner X; Kiefer F; Hermann D
    Eur J Clin Pharmacol; 2013 Dec; 69(12):2021-5. PubMed ID: 23989299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schedules of controlled substances: placement of pregabalin into schedule V. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2005 Jul; 70(144):43633-5. PubMed ID: 16050051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gabapentin and pregabalin: abuse and addiction.
    Prescrire Int; 2012 Jun; 21(128):152-4. PubMed ID: 22822593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [To misunderstand about pregabalin abuse].
    Westin AA; Helland A; Strøm EJ
    Tidsskr Nor Laegeforen; 2011 Apr; 131(7):663. PubMed ID: 21494291
    [No Abstract]   [Full Text] [Related]  

  • 26. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.
    Bandelow B; Wedekind D; Leon T
    Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pregabalin for the reduction of opiate withdrawal symptoms].
    Kämmerer N; Lemenager T; Grosshans M; Kiefer F; Hermann D
    Psychiatr Prax; 2012 Oct; 39(7):351-2. PubMed ID: 22689280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The prescription registry and abuse of pregabalin].
    Landmark CJ; Fossmark H; Larsson PG; Rytter E; Johannessen SI
    Tidsskr Nor Laegeforen; 2011 Feb; 131(3):223. PubMed ID: 21304565
    [No Abstract]   [Full Text] [Related]  

  • 30. Concerns about pregabalin: further experience with its potential of causing addictive behaviors.
    Gahr M; Franke B; Freudenmann RW; Kölle MA; Schönfeldt-Lecuona C
    J Addict Med; 2013; 7(2):147-9. PubMed ID: 23519046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical experiences with pregabalin in the treatment of focal epilepsies].
    Gil-Nagel Rein A; Gómez-Alonso J
    Rev Neurol; 2005 May 16-31; 40(10):609-13. PubMed ID: 15926135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Abuse of pregabalin].
    Bramness JG
    Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1703-4. PubMed ID: 20835274
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Feb 16-28; 42(4):223-37. PubMed ID: 16521062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregabalin.
    Dworkin RH; Kirkpatrick P
    Nat Rev Drug Discov; 2005 Jun; 4(6):455-6. PubMed ID: 15959952
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pregabalin. A new treatment for neuropathic pain].
    López-Trigo J; Sancho Rieger J
    Neurologia; 2006 Mar; 21(2):96-103. PubMed ID: 16525916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregabalin effect on steady-state pharmacokinetics of carbamazepine, lamotrigine, phenobarbital, phenytoin, topiramate, valproate, and tiagabine.
    Bockbrader HN; Burger P; Knapp L
    Epilepsia; 2011 Feb; 52(2):405-9. PubMed ID: 21314678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregabalin and duloxetine for the treatment of neuropathic pain disorders.
    Terneus W
    J Pain Palliat Care Pharmacother; 2007; 21(1):79-84. PubMed ID: 17430838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pregabalin (Lyrica) and neuropathic pain syndromes].
    Jacquy J; Lossignol D; Sternon J
    Rev Med Brux; 2006; 27(5):445-50. PubMed ID: 17144644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregabalin Abuse amongst Opioid Substitution Treatment Patients.
    McNamara S; Stokes S; Kilduff R; Shine A
    Ir Med J; 2015; 108(10):309-10. PubMed ID: 26817289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pregabalin and abuse potential--a clarification].
    Bergan A; Hjelvin E
    Tidsskr Nor Laegeforen; 2013 May; 133(10):1045. PubMed ID: 23712141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.